Status:
COMPLETED
Intravenous Lignocaine vs Placebo
Lead Sponsor:
Indus Hospital and Health Network
Conditions:
Hemodynamic Stability Post Intubation in Laryngoscopy Surgery
Eligibility:
All Genders
20-60 years
Phase:
PHASE3
Brief Summary
To assess the mean hemodynamic responses post-intubation in patients given intravenous lignocaine pre-intubation as compared to a placebo pre-intubation in patients undergoing laryngoscopy surgery
Detailed Description
After identifying the candidate, details will be carefully discussed with the subject. The subject (or, when necessary, the parent or legal guardian if the subject is younger than 18 years of age or u...
Eligibility Criteria
Inclusion
- ASA I and II
- Age 20-60 years
- Mallampatti , II
- All surgeries are done under GA
- Both genders
- Those patients giving informed consent
Exclusion
- Difficult airway assessed during pre-op anaesthesia assessment
- Unanticipated difficult airway based on the previous history of difficult intubation
- BMI \>30,
- Micrognathia and microglossia based on pre-op anaesthesia assessment,
- Diabetic patient with autonomic dysfunction liver disease, cardiovascular disease, pheochromocytoma, Cushing syndrome
- Patients who do not give informed consent
Key Trial Info
Start Date :
December 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2018
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03787069
Start Date
December 20 2017
End Date
July 20 2018
Last Update
December 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Indus Hospital
Karachi, Sindh, Pakistan, 75500